Generic Name and Formulations:
Efinaconazole 10%; topical soln; contains alcohol.
Bausch Health Companies Inc.
Indications for JUBLIA:
Treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.
Apply to affected toenail(s) once daily for 48 weeks using the integrated flow-through brush applicator. Ensure complete cover of the toenail, toenail folds, toenail bed, hyponychium, and the undersurface of the toenail plate.
Not for oral, ophthalmic, or intravaginal use. Product is flammable. Pregnancy (Cat.C). Nursing mothers.
Ingrown toenail, application site reactions (eg, dermatitis, vesicles, pain).
Bottle (4mL, 8mL)—1 (w. brush applicator)
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Prazosin May Be Effective as Treatment for Alcohol Use Disorder
- Text Message Reminders Improve Medication Adherence in Bipolar I Disorder
- Improving Medication Adherence in ADHD Lowers Risk for Oppositional Defiant Disorder, Conduct Disorder in Adulthood
- High Suicidality Among Children With ADHD Mediated by Family Functioning, Psychiatry Comorbidities
- Pilot Study Investigates Lithium vs Quetiapine for Bipolar Spectrum Disorder
- How Personalized Hospital Ratings May Drive Patient-Specific Care in the Digital Age